Embolus vs EHA Guidelines

Embolus originates from the popular website, Practical-Haemostasis.com, and is our second Haemostasis product. See sangmedicine.com for additional information. The app offers clinical cases and data interpretation exercises in laboratory haemostasis and is designed to both assess and reinforce your knowledge in this area and in addition to assist with your preparations for post-graduate examinations in Haematology. Embolus is intended for doctors in haematology training programmes, laboratory staff and anyone with an interest in laboratory haemostasis. #FEATURES# STUDY 70 different cases addressing 6 key areas of Haemostasis: - Screening Tests - Factor Assays - Genetic Tests - Platelet Function Tests - Thrombophilia Tests - Miscellaneous Tests EXPLORE realistic patient and laboratory data FAMILIARISE yourself with exam question format TRACK your progress and highlight areas that you feel require additional reading/review

The EHA Guidelines app is a free service offered by the European Hematology Association. The app contains hematology clinical practice guidelines, interactive tools, diagnostic algorithms, calculators, and more. The initial release features four pilot guidelines with full implementation of tools and interactivity, along with more guideline PDFs. Interactive versions of these guidelines are coming soon. App features: - Interactive guidelines for easy navigation - Full-text guidelines or direct link to guidelines - Interactive algorithms and tools - Add notes and bookmark important pages - Print or share important content or interactive pages For more information please contact us at guidelinesapp@ehaweb.org Note: These guidelines reflect the current state of scientific research and have been compiled with careful consideration of evidence-based criteria. Doctors are advised to fully incorporate these guidelines into their clinical judgment. However, the editor, authors, and software developer cannot guarantee the completeness, accuracy, correctness, and timeliness of the contents. Each user is requested to check the information provided in this app in each individual case and to act on their own responsibility. Any diagnosis, therapy, dosage, or application is at the user’s own risk.